Skip to Content

S 063 (Agrylin 0.5 mg)

Generic Name: anagrelide

Pill imprint S 063 has been identified as Agrylin 0.5 mg.

Agrylin is used in the treatment of thrombocythemia; chronic myelogenous leukemia and belongs to the drug class miscellaneous uncategorized agents. Risk cannot be ruled out during pregnancy. Agrylin 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Agrylin 0.5 mg S 063
Agrylin 0.5 mg S 063 Front
Agrylin 0.5 mg S 063 Back
Discount Card Promo
Agrylin
Generic Name:
anagrelide
Imprint:
S 063
Strength:
0.5 mg
Color:
White
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous uncategorized agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Shire US Inc.
National Drug Code (NDC):
54092-0063
Inactive Ingredients:
lactose anhydrous
crospovidone
lactose monohydrate
magnesium stearate
microcrystalline cellulose
povidone

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide